http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 01 Jun 2026 08:50:34 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html <p>LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) announced a strategic transformation from a clinical-stage pharmaceutical company to an AI energy infrastructure equipment and services platform. The company said it will focus on meeting power demands of AI and hyperscale data centers.</p> <p>Stuart D. Porter, founder and managing partner of Denham Capital Management LP, joined LIXTE's board of directors. Porter has overseen more than $12 billion of invested and committed capital across energy sectors since founding Denham Capital in 2004.</p> <p>The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html Mon, 01 Jun 2026 08:50:34 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html <p>LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) announced a strategic transformation from a clinical-stage pharmaceutical company to an AI energy infrastructure equipment and services platform. The company said it will focus on meeting power demands of AI and hyperscale data centers.</p> <p>Stuart D. Porter, founder and managing partner of Denham Capital Management LP, joined LIXTE's board of directors. Porter has overseen more than $12 billion of invested and committed capital across energy sectors since founding Denham Capital in 2004.</p> <p>The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html Mon, 01 Jun 2026 08:50:34 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html <p>LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) announced a strategic transformation from a clinical-stage pharmaceutical company to an AI energy infrastructure equipment and services platform. The company said it will focus on meeting power demands of AI and hyperscale data centers.</p> <p>Stuart D. Porter, founder and managing partner of Denham Capital Management LP, joined LIXTE's board of directors. Porter has overseen more than $12 billion of invested and committed capital across energy sectors since founding Denham Capital in 2004.</p> <p>The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html Mon, 01 Jun 2026 08:50:34 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html <p>LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) announced a strategic transformation from a clinical-stage pharmaceutical company to an AI energy infrastructure equipment and services platform. The company said it will focus on meeting power demands of AI and hyperscale data centers.</p> <p>Stuart D. Porter, founder and managing partner of Denham Capital Management LP, joined LIXTE's board of directors. Porter has overseen more than $12 billion of invested and committed capital across energy sectors since founding Denham Capital in 2004.</p> <p>The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html Mon, 01 Jun 2026 08:50:34 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html <p>LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) announced a strategic transformation from a clinical-stage pharmaceutical company to an AI energy infrastructure equipment and services platform. The company said it will focus on meeting power demands of AI and hyperscale data centers.</p> <p>Stuart D. Porter, founder and managing partner of Denham Capital Management LP, joined LIXTE's board of directors. Porter has overseen more than $12 billion of invested and committed capital across energy sectors since founding Denham Capital in 2004.</p> <p>The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html Mon, 01 Jun 2026 08:50:34 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html <p>LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) announced a strategic transformation from a clinical-stage pharmaceutical company to an AI energy infrastructure equipment and services platform. The company said it will focus on meeting power demands of AI and hyperscale data centers.</p> <p>Stuart D. Porter, founder and managing partner of Denham Capital Management LP, joined LIXTE's board of directors. Porter has overseen more than $12 billion of invested and committed capital across energy sectors since founding Denham Capital in 2004.</p> <p>The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html Mon, 01 Jun 2026 08:50:34 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html <p>LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) announced a strategic transformation from a clinical-stage pharmaceutical company to an AI energy infrastructure equipment and services platform. The company said it will focus on meeting power demands of AI and hyperscale data centers.</p> <p>Stuart D. Porter, founder and managing partner of Denham Capital Management LP, joined LIXTE's board of directors. Porter has overseen more than $12 billion of invested and committed capital across energy sectors since founding Denham Capital in 2004.</p> <p>The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued http://www.streetinsider.com/Board+Changes/LIXTE+Biotechnology+pivots+to+AI+energy+infrastructure+services/26580096.html Mon, 01 Jun 2026 08:50:34 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html <p><i>Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastructure</i></p> <p align="justify"><strong>BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its strategic transformation into an AI energy infrastructure equipment &amp; services platform focused on meeting the rapidly growing power demands of AI and hyperscale data centers. In connection with this transformation, Stuart D. Porter, Founder, Managing Partner, Chief Executive Officer and Chief Investment Officer of Denham Capital Management http://www.streetinsider.com/Globe+Newswire/LIXTE+Biotechnology+Announces+Strategic+Transformation+into+AI+Energy+Infrastructure+Equipment+%26amp%3B+Services%3B+Stuart+D.+Porter%2C+Founder+of+Denham+Capital%2C+to+Join+Board+of+Directors/26580090.html Mon, 01 Jun 2026 08:50:00 -0400 A.01785157 A.41165932 LIXT LIXTW O.03535928 O.07116546 O.20401274 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Files+First+Quarter+2026+Quarterly+Report+on+Form+10-Q%3B+Provides+Operational+Progress+Update/26496678.html <p align="justify"><strong>BOCA RATON, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (“SEC”) for the first quarter ended March 31, 2026. The report is available on the Company’s website, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=IATdX2ZAA8HzGY-rAKVx6kFelF0oegGp7rVfJEyJcpheqGuCDhZBuj4fhlZgBs7gtHhb4DZexLyu5myvJq6wVQ==" rel="nofollow" target="_blank">www.lixte.com</a>, and on the SEC’s website, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=z2xpTpRH2h7F4RID1R7xfydCIIqziIMFrtjLKg-pNX300NrF7o2ub3lENyOb_Dw9pieWBOWSa2y35RwpPa46TA==" rel="nofollow" target="_blank">www.sec.gov</a>.</p> <p align="justify">“We are making progress in advancing our lead compound, LB-100, which has consistently shown synergy http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Files+First+Quarter+2026+Quarterly+Report+on+Form+10-Q%3B+Provides+Operational+Progress+Update/26496678.html Thu, 14 May 2026 17:18:00 -0400 A.33615634 A.41238129 LIXT LIXTW O.07116439 O.07116546 O.57576170 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Files+First+Quarter+2026+Quarterly+Report+on+Form+10-Q%3B+Provides+Operational+Progress+Update/26496678.html <p align="justify"><strong>BOCA RATON, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (“SEC”) for the first quarter ended March 31, 2026. The report is available on the Company’s website, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=IATdX2ZAA8HzGY-rAKVx6kFelF0oegGp7rVfJEyJcpheqGuCDhZBuj4fhlZgBs7gtHhb4DZexLyu5myvJq6wVQ==" rel="nofollow" target="_blank">www.lixte.com</a>, and on the SEC’s website, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=z2xpTpRH2h7F4RID1R7xfydCIIqziIMFrtjLKg-pNX300NrF7o2ub3lENyOb_Dw9pieWBOWSa2y35RwpPa46TA==" rel="nofollow" target="_blank">www.sec.gov</a>.</p> <p align="justify">“We are making progress in advancing our lead compound, LB-100, which has consistently shown synergy http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Files+First+Quarter+2026+Quarterly+Report+on+Form+10-Q%3B+Provides+Operational+Progress+Update/26496678.html Thu, 14 May 2026 17:18:00 -0400 A.33615634 A.41238129 LIXT LIXTW O.07116439 O.07116546 O.57576170 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Files+First+Quarter+2026+Quarterly+Report+on+Form+10-Q%3B+Provides+Operational+Progress+Update/26496678.html <p align="justify"><strong>BOCA RATON, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (“SEC”) for the first quarter ended March 31, 2026. The report is available on the Company’s website, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=IATdX2ZAA8HzGY-rAKVx6kFelF0oegGp7rVfJEyJcpheqGuCDhZBuj4fhlZgBs7gtHhb4DZexLyu5myvJq6wVQ==" rel="nofollow" target="_blank">www.lixte.com</a>, and on the SEC’s website, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=z2xpTpRH2h7F4RID1R7xfydCIIqziIMFrtjLKg-pNX300NrF7o2ub3lENyOb_Dw9pieWBOWSa2y35RwpPa46TA==" rel="nofollow" target="_blank">www.sec.gov</a>.</p> <p align="justify">“We are making progress in advancing our lead compound, LB-100, which has consistently shown synergy http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Files+First+Quarter+2026+Quarterly+Report+on+Form+10-Q%3B+Provides+Operational+Progress+Update/26496678.html Thu, 14 May 2026 17:18:00 -0400 A.33615634 A.41238129 LIXT LIXTW O.07116439 O.07116546 O.57576170 http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Files+First+Quarter+2026+Quarterly+Report+on+Form+10-Q%3B+Provides+Operational+Progress+Update/26496678.html <p align="justify"><strong>BOCA RATON, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- </strong>LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (“SEC”) for the first quarter ended March 31, 2026. The report is available on the Company’s website, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=IATdX2ZAA8HzGY-rAKVx6kFelF0oegGp7rVfJEyJcpheqGuCDhZBuj4fhlZgBs7gtHhb4DZexLyu5myvJq6wVQ==" rel="nofollow" target="_blank">www.lixte.com</a>, and on the SEC’s website, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=z2xpTpRH2h7F4RID1R7xfydCIIqziIMFrtjLKg-pNX300NrF7o2ub3lENyOb_Dw9pieWBOWSa2y35RwpPa46TA==" rel="nofollow" target="_blank">www.sec.gov</a>.</p> <p align="justify">“We are making progress in advancing our lead compound, LB-100, which has consistently shown synergy http://www.streetinsider.com/Press+Releases/LIXTE+Biotechnology+Files+First+Quarter+2026+Quarterly+Report+on+Form+10-Q%3B+Provides+Operational+Progress+Update/26496678.html Thu, 14 May 2026 17:18:00 -0400 A.33615634 A.41238129 LIXT LIXTW O.07116439 O.07116546 O.57576170